Representation is Prevention: Closing the Sex Gap in Novel Cardiovascular Clinical Trials. [PDF]
Shah NP, Gulati M.
europepmc +1 more source
Angiopoietin-like Protein 3 (ANGPTL3) Targeting in the Management of Dyslipidemias. [PDF]
Kosmas CE +4 more
europepmc +1 more source
Advanced therapy in familial hypercholesterolemia. [PDF]
Gao E, Brunham LR, Goldman RD.
europepmc +1 more source
Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors. [PDF]
Patel J +5 more
europepmc +1 more source
ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting. [PDF]
Weng S, Ding C, Lin J, Chai D.
europepmc +1 more source
Current and Emerging Pharmacological Therapies for Hypertriglyceridemia. [PDF]
Alhomoud IS.
europepmc +1 more source
Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives. [PDF]
Tamehri Zadeh SS, Toth PP, Banach M.
europepmc +1 more source
Severe polyarterial involvement in a 16-year-old with homozygous familial hypercholesterolaemia: a case report. [PDF]
Benabdellah M +4 more
europepmc +1 more source
Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia. [PDF]
Alkhairy A +4 more
europepmc +1 more source
Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary. [PDF]
Gaudet D +18 more
europepmc +1 more source

